Andrew Avins to Coronary Disease
This is a "connection" page, showing publications Andrew Avins has written about Coronary Disease.
Connection Strength
1.455
-
Placebo adherence and mortality in the Heart and Estrogen/Progestin Replacement Study. Am J Med. 2012 Aug; 125(8):804-10.
Score: 0.383
-
Do triglycerides provide meaningful information about heart disease risk? Arch Intern Med. 2000 Jul 10; 160(13):1937-44.
Score: 0.166
-
Improving the prediction of coronary heart disease to aid in the management of high cholesterol levels: what a difference a decade makes. JAMA. 1998 Feb 11; 279(6):445-9.
Score: 0.140
-
Lowering risk without lowering cholesterol: implications for national cholesterol policy. Ann Intern Med. 1996 Sep 15; 125(6):502-6.
Score: 0.127
-
Triglyceride concentration and coronary heart disease. BMJ. 1995 Jan 28; 310(6974):259-60.
Score: 0.114
-
Triglyceride concentration and coronary heart disease. BMJ. 1994 Nov 26; 309(6966):1440-1.
Score: 0.112
-
Triglyceride concentration and coronary heart disease. BMJ. 1994 Jul 02; 309(6946):2-3.
Score: 0.109
-
Asymptomatic hypertriglyceridaemia. BMJ. 1992 Feb 15; 304(6824):394-6.
Score: 0.093
-
Hepatic effects of lovastatin exposure in patients with liver disease: a retrospective cohort study. Drug Saf. 2008; 31(4):325-34.
Score: 0.070
-
Effect of intense lifestyle modification and cardiac rehabilitation on psychosocial cardiovascular disease risk factors and quality of life. Behav Modif. 2006 Jul; 30(4):507-25.
Score: 0.063
-
Cardiovascular risk reductions associated with aggressive lifestyle modification and cardiac rehabilitation. Heart Lung. 2003 Nov-Dec; 32(6):374-82.
Score: 0.052
-
Reporting clinical trial results. Ann Intern Med. 1993 Jul 01; 119(1):93-4.
Score: 0.025